Related Experiment Video
Updated: Jun 16, 2026
02:28
Measuring Psoriasis Severity at Home
Published on: March 1, 2024
Progress in understanding the immunopathogenesis of psoriasis
R K H Mak1, C Hundhausen, F O Nestle
1St. John's Institute of Dermatology. King's College London School of Medicine. London, United Kingdom. rose.mak@kcl.ac.uk
Actas Dermo-Sifiliograficas
|January 26, 2010
Summary
Understanding psoriasis immunopathogenesis has advanced through bench-to-bedside research. Key discoveries include the interleukin-23/T-helper 17 (IL-23/Th17) axis, driving new biologic therapies for psoriasis.
Area of Science:
- Immunology
- Dermatology
- Translational Research
Background:
- Psoriasis is a chronic inflammatory skin condition.
- Its immunopathogenesis involves complex interactions between innate and adaptive immune systems.
- Understanding these mechanisms is crucial for developing effective treatments.
Purpose of the Study:
- To review the progress in understanding psoriasis immunopathogenesis.
- To highlight the bidirectional translation between basic research and clinical practice.
- To discuss current and future therapeutic targets.
Main Methods:
- Literature review of bench research and clinical studies on psoriasis.
- Explanation of immune system components and pathways involved in psoriasis.
- Analysis of the impact of key discoveries on therapeutic development.
Main Results:
- Significant progress in understanding psoriasis pathogenesis through translational research.
- Detailed explanation of the roles of innate and adaptive immunity.
- Identification of the IL-23/Th17 axis as a critical pathway.
- Successful development of novel biologic therapies targeting this axis.
Conclusions:
- Translational research is vital for advancing psoriasis treatment.
- The IL-23/Th17 pathway represents a major therapeutic target.
- Further research into immune pathways holds promise for future psoriasis therapies.
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...